Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-β-lactamase gene in clinical isolates of Bacteroides fragilis

Clinical Microbiology and Infection

Volumn 14, Issue 10, 2008, Pages 973-977

  Bogaerts, Pierre ^a   Engelhardt, A ^b   Berhin, C ^a   Bylund, L ^b   Ho, P ^b   Yusof, A ^b   Glupczynski, Y ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b AB BIODISK   (Sweden)

Author keywords

Bacteroides; Etest; Metallo lactamase; Phenotypic detection

Indexed keywords

BETA LACTAMASE CFIA; CARBAPENEM; EDETIC ACID; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; EPSILOMETER TEST; GENOTYPE PHENOTYPE CORRELATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

BACTEROIDES; BACTEROIDES FRAGILIS;

EID: 52249121424     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02065.x     Document Type: Article

References (20)

1. Snydman DR, Jacobus NV, McDermott LA et al. National survey on the susceptibility of Bacteroides fragilis group: Report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother 2007; 51: 1649-1655.
2. Wybo I, Piérard D, Verschraegen I et al. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 2007; 59: 132-139.
3. Edwards R, Hawkyard CV, Garvey MT et al. Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK. J Antimicrob Chemother 1999; 43: 273-276.
4. Podglajen I, Breuil J, Casin I et al. Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol 1995; 177: 5270-5275.
5. Soki J, Edwards R, Hedberg M et al. Examination of cfiA- mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey. Int J Antimicrob Agents 2006; 28: 497-502.
6. Edwards R, Greenwood D. Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis. J Antimicrob Chemother 1996; 38: 941-951.
7. Soki J, Edwards R, Urban E et al. Screening of isolates from faeces for carbapenem-resistant Bacteroides strains; existence of strains with novel types of resistance mechanisms. Int J Antimicrob Agents 2004; 24: 450-454.
8. Piriz S, Vadillo S, Quesada A et al. Relationship between penicillin-binding protein patterns and β-lactamases in clinical isolates of Bacteroides fragilis with different susceptibility to β-lactam antibiotics. J Med Microbiol 2004; 53: 213-221.
9. Ayala J, Quesada A, Vadillo S et al. Penicillin-binding proteins of Bacteroides fragilis and their role in the resistance to imipenem of clinical isolates. J Med Microbiol 2005; 54: 1055-1064.
10. Thompson JS, Malamy MH. Sequencing the gene for an imipenem-cefoxitin-hydrolysing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus β-lactamase. II. J Bacteriol 1990; 172: 2584-2593.
11. Edwards R, Read PN. Expression of the carbapenemase gene (cfiA) in Bacteroides fragilis. J Antimicrob Chemother 2000; 46: 1009-1012.
12. Podglajen I, Breuil J, Collatz E. Insertion of a novel DNA sequence, IS1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroïdes fragilis. Mol Microbiol 1994; 12: 105-114.
13. Soki J, Fodor E, Hecht DW et al. Molecular characterization of imipenem-resistant, cfiA -positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait. J Med Microbiol 2004; 53: 413-419.
14. Kato N, Yamazoe K, Han C-G et al. New insertion sequence elements in the upstream region of cfiA in imipenem-resistant Bacteroides fragilis strains. Antimicrob Agents Chemother 2003; 47: 979-985.
15. Yamazoe K, Kato N, Kato H et al. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance. Antimicrob Agents Chemother 1999; 43: 2808-2810.
16. Podgaljen I, Breuil J, Bordon F et al. A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after one-step mutation. FEMS Microbiol Lett 1992; 91: 21-30.
17. Yang Y, Testa RT, Bhachech N et al. Biochemical characterization of novel tetrahydrofuranyl 1β-methylcarbapenems: Stability to hydrolysis by renal dehydropeptidases and bacterial β-lactamases, binding to penicillin binding proteins, and permeability properties. Antimicrob Agents Chemother 1999; 43: 2904-2909.
18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, sixteenth informational supplement. Approved Standard M100 S16. Wayne, PA: CLSI, 2006.
19. Walsh TR, Bolmström A, Qwärnström A, Gales A. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J Antimicrob Chemother 2002; 40: 2755-2759.
20. Galani I, Rekatsina PD, Hatzaki D et al. Evaluation of different laboratory tests for the detection of metallo-β-lactamase production in Enterobacteriaceae. J Antimicrob Chemother 2008; 61: 548-553.